Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Millennium Pharmaceuticals Inc (MLNM) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Millennium Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1002637.
Total stock buying since 2006: $0.
Total stock sales since 2006: $20,950,401.
Total stock option exercises since 2006: $7,775,462.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 0 | $0 | 191,645 | $2,729,656 | 7,373 | $59,905 |
| 2007 | 0 | $0 | 1,141,634 | $13,890,402 | 567,216 | $4,868,086 |
| 2006 | 0 | $0 | 395,619 | $4,330,343 | 466,448 | $2,847,471 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-05 | 0 | $0 | 2,041 | $50,780 | 0 | $0 |
| 2008-03 | 0 | $0 | 74,835 | $1,001,078 | 0 | $0 |
| 2008-02 | 0 | $0 | 65,104 | $896,446 | 3,561 | $28,933 |
| 2008-01 | 0 | $0 | 49,665 | $781,352 | 3,812 | $30,972 |
| 2007-12 | 0 | $0 | 276,487 | $4,269,650 | 334,134 | $3,086,139 |
| 2007-11 | 0 | $0 | 112,468 | $1,530,344 | 25,000 | $210,250 |
| 2007-10 | 0 | $0 | 96,297 | $1,056,216 | 0 | $0 |
| 2007-09 | 0 | $0 | 177,500 | $1,838,328 | 116,505 | $892,568 |
| 2007-08 | 0 | $0 | 40,000 | $399,150 | 0 | $0 |
| 2007-07 | 0 | $0 | 56,548 | $592,897 | 1,600 | $104 |
| 2007-06 | 0 | $0 | 49,500 | $512,423 | 0 | $0 |
| 2007-05 | 0 | $0 | 51,929 | $569,184 | 0 | $0 |
| 2007-04 | 0 | $0 | 38,500 | $446,260 | 8,500 | $58,480 |
| 2007-03 | 0 | $0 | 121,798 | $1,321,213 | 52,071 | $393,154 |
| 2007-02 | 0 | $0 | 110,765 | $1,246,279 | 19,787 | $166,408 |
| 2007-01 | 0 | $0 | 9,842 | $108,458 | 9,619 | $60,983 |
| 2006-12 | 0 | $0 | 0 | $0 | 18,948 | $171,054 |
| 2006-11 | 0 | $0 | 35,436 | $406,300 | 20,000 | $126,800 |
| 2006-10 | 0 | $0 | 172,500 | $2,008,117 | 112,500 | $1,099,462 |
| 2006-09 | 0 | $0 | 10,003 | $109,532 | 0 | $0 |
| 2006-08 | 0 | $0 | 177,680 | $1,806,394 | 0 | $0 |
| 2006-07 | 0 | $0 | 0 | $0 | 75,000 | $295,275 |
| 2006-05 | 0 | $0 | 0 | $0 | 80,000 | $384,960 |
| 2006-04 | 0 | $0 | 0 | $0 | 80,000 | $384,960 |
| 2006-03 | 0 | $0 | 0 | $0 | 80,000 | $384,960 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-05-01 | Protopapas Anna (Senior Vice President) | Sale | 2,041 | 24.88 | 50,780 |
| 2008-03-11 | Keating Laurie B. (SVP and General Counsel) | Sale | 6,784 | 12.82 | 86,970 |
| 2008-03-11 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 4,429 | 12.82 | 56,779 |
| 2008-03-07 | Protopapas Anna (Senior Vice President) | Sale | 2,010 | 13.34 | 26,811 |
| 2008-03-07 | Dunsire Deborah (President and CEO) | Sale | 14,096 | 13.34 | 188,026 |
| 2008-03-07 | Keating Laurie B. (SVP and General Counsel) | Sale | 3,216 | 13.34 | 42,898 |
| 2008-03-07 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 5,989 | 13.34 | 79,887 |
| 2008-03-06 | Simonian Nancy A (Chief Medical Officer) | Sale | 11,729 | 13.25 | 155,409 |
| 2008-03-05 | Bolen Joseph B (Chief Scientific Officer) | Sale | 5,606 | 13.55 | 75,955 |
| 2008-03-05 | Smith Peter (Senior Vice President) | Sale | 5,773 | 13.55 | 78,218 |
| 2008-03-05 | Simonian Nancy A (Chief Medical Officer) | Sale | 5,813 | 13.55 | 78,760 |
| 2008-03-03 | Simonian Nancy A (Chief Medical Officer) | Sale | 3,150 | 13.99 | 44,068 |
| 2008-03-03 | Keating Laurie B. (SVP and General Counsel) | Sale | 6,240 | 13.99 | 87,297 |
| 2008-02-29 | Bolen Joseph B (Chief Scientific Officer) | Sale | 1,802 | 13.68 | 24,642 |
| 2008-02-29 | Simonian Nancy A (Chief Medical Officer) | Sale | 1,850 | 13.68 | 25,298 |
| 2008-02-29 | Bianchi Christophe (Executive Vice President) | Sale | 9,320 | 13.67 | 127,432 |
| 2008-02-29 | Protopapas Anna (Senior Vice President) | Sale | 4,289 | 13.67 | 58,647 |
| 2008-02-29 | Dunsire Deborah (President and CEO) | Sale | 23,820 | 13.67 | 325,643 |
| 2008-02-29 | Gansler Stephen M (Senior Vice President) | Sale | 5,794 | 13.67 | 79,221 |
| 2008-02-29 | Keating Laurie B. (SVP and General Counsel) | Sale | 4,075 | 13.67 | 55,721 |
| 2008-02-29 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 5,480 | 13.68 | 74,939 |
| 2008-02-25 | Gansler Stephen M (Senior Vice President) | Sale | 1,650 | 13.33 | 21,994 |
| 2008-02-19 | Protopapas Anna (Senior Vice President) | Sale | 3,561 | 14.03 | 49,960 |
| 2008-02-19 | Protopapas Anna (Senior Vice President) | Option Ex | 3,561 | 8.12 | 28,933 |
| 2008-02-04 | Bianchi Christophe (Executive Vice President) | Sale | 3,463 | 15.29 | 52,949 |
| 2008-01-18 | Protopapas Anna (Senior Vice President) | Sale | 3,812 | 16.53 | 63,012 |
| 2008-01-18 | Protopapas Anna (Senior Vice President) | Option Ex | 3,812 | 8.12 | 30,972 |
| 2008-01-09 | Levin Mark J (Director) | Sale | 10,000 | 15.12 | 151,384 |
| 2008-01-08 | Protopapas Anna (Senior Vice President) | Sale | 1,071 | 15.23 | 16,311 |
| 2008-01-08 | Gansler Stephen M (Senior Vice President) | Sale | 1,280 | 15.23 | 19,494 |
| 2008-01-04 | Keating Laurie B. (SVP and General Counsel) | Sale | 5,281 | 14.85 | 78,422 |
| 2008-01-03 | Protopapas Anna (Senior Vice President) | Sale | 4,091 | 16.11 | 65,906 |
| 2008-01-03 | Keating Laurie B. (SVP and General Counsel) | Sale | 4,830 | 16.11 | 77,811 |
| 2008-01-02 | Levin Mark J (Director) | Sale | 10,000 | 16.17 | 161,305 |
| 2007-12-26 | Levin Mark J (Director) | Sale | 10,000 | 15.57 | 155,720 |
| 2007-12-19 | Levin Mark J (Director) | Sale | 10,000 | 14.95 | 148,724 |
| 2007-12-17 | Protopapas Anna (Senior Vice President) | Option Ex | 143,750 | 11.51 | 1,654,562 |
| 2007-12-14 | Heidrich A Grant Iii (Director) | Sale | 25,584 | 15.43 | 394,633 |
| 2007-12-13 | Simonian Nancy A (Chief Medical Officer) | Sale | 113,063 | 15.44 | 1,745,127 |
| 2007-12-13 | Simonian Nancy A (Chief Medical Officer) | Option Ex | 110,834 | 7.89 | 874,147 |
| 2007-12-12 | Levin Mark J (Director) | Sale | 10,000 | 15.65 | 157,189 |
| 2007-12-11 | Homcy Charles J (Director) | Sale | 59,238 | 15.81 | 936,434 |
| 2007-12-11 | Homcy Charles J (Director) | Option Ex | 59,238 | 6.49 | 384,454 |
| 2007-12-06 | Bolen Joseph B (Chief Scientific Officer) | Sale | 20,312 | 15.18 | 308,336 |
| 2007-12-06 | Bolen Joseph B (Chief Scientific Officer) | Option Ex | 20,312 | 8.52 | 172,976 |
| 2007-12-06 | Keating Laurie B. (SVP and General Counsel) | Sale | 1,716 | 15.18 | 26,048 |
| 2007-12-05 | Levin Mark J (Director) | Sale | 10,000 | 15.22 | 151,918 |
| 2007-12-03 | Protopapas Anna (Senior Vice President) | Sale | 5,674 | 14.55 | 82,556 |
| 2007-11-28 | Levin Mark J (Director) | Sale | 10,000 | 15.23 | 152,310 |
| 2007-11-26 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 14.32 | 71,600 |
| 2007-11-21 | Levin Mark J (Director) | Sale | 10,000 | 14.12 | 140,972 |
| 2007-11-19 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 13.62 | 68,100 |
| 2007-11-14 | Levin Mark J (Director) | Sale | 10,000 | 13.96 | 139,348 |
| 2007-11-12 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 13.41 | 67,050 |
| 2007-11-07 | Levin Mark J (Director) | Sale | 10,000 | 13.13 | 131,596 |
| 2007-11-05 | Protopapas Anna (Senior Vice President) | Sale | 5,000 | 12.62 | 63,099 |
| 2007-11-05 | Keating Laurie B. (SVP and General Counsel) | Sale | 25,000 | 12.68 | 316,875 |
| 2007-11-05 | Keating Laurie B. (SVP and General Counsel) | Option Ex | 25,000 | 8.41 | 210,250 |
| 2007-11-01 | Protopapas Anna (Senior Vice President) | Sale | 368 | 12.00 | 4,416 |
| 2007-10-10 | Bolen Joseph B (Chief Scientific Officer) | Sale | 11,297 | 11.00 | 124,267 |
| 2007-10-10 | Kucherlapati Raju S (Director) | Sale | 75,000 | 11.06 | 829,500 |
| 2007-10-03 | Levin Mark J (Director) | Sale | 10,000 | 10.24 | 102,449 |
| 2007-09-26 | Levin Mark J (Director) | Sale | 10,000 | 10.14 | 101,420 |
| 2007-09-19 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 7,436 | 10.67 | 79,342 |
| 2007-09-19 | Homcy Charles J (Director) | Sale | 40,000 | 10.68 | 427,200 |
| 2007-09-19 | Levin Mark J (Director) | Sale | 10,000 | 10.56 | 105,570 |
| 2007-09-18 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 10,064 | 10.58 | 106,477 |
| 2007-09-18 | Homcy Charles J (Director) | Sale | 40,000 | 10.33 | 413,240 |
| 2007-09-18 | Homcy Charles J (Director) | Option Ex | 60,831 | 8.44 | 513,413 |
| 2007-09-17 | Protopapas Anna (Senior Vice President) | Option Ex | 25,674 | 4.91 | 125,956 |
| 2007-09-17 | Homcy Charles J (Director) | Sale | 10,000 | 9.76 | 97,630 |
| 2007-09-12 | Levin Mark J (Director) | Sale | 10,000 | 10.00 | 99,960 |
| 2007-09-05 | Homcy Charles J (Director) | Option Ex | 30,000 | 8.44 | 253,199 |
| 2007-09-05 | Levin Mark J (Director) | Sale | 10,000 | 10.15 | 101,489 |
| 2007-09-04 | Homcy Charles J (Director) | Sale | 30,000 | 10.20 | 306,000 |
| 2007-08-29 | Levin Mark J (Director) | Sale | 10,000 | 9.77 | 97,710 |
| 2007-08-22 | Levin Mark J (Director) | Sale | 10,000 | 9.83 | 98,260 |
| 2007-08-15 | Levin Mark J (Director) | Sale | 10,000 | 10.23 | 102,280 |
| 2007-08-01 | Levin Mark J (Director) | Sale | 10,000 | 10.09 | 100,900 |
| 2007-07-31 | Heidrich A Grant Iii (Director) | Sale | 1,600 | 10.12 | 16,191 |
| 2007-07-31 | Heidrich A Grant Iii (Director) | Option Ex | 1,600 | .07 | 104 |
| 2007-07-30 | Smith Peter (Senior Vice President) | Sale | 11,284 | 10.11 | 114,081 |
| 2007-07-19 | Dunsire Deborah (President and CEO) | Sale | 33,664 | 10.61 | 357,175 |
| 2007-07-11 | Levin Mark J (Director) | Sale | 10,000 | 10.54 | 105,450 |
| 2007-06-27 | Levin Mark J (Director) | Sale | 10,000 | 10.33 | 102,673 |
| 2007-06-20 | Levin Mark J (Director) | Sale | 10,000 | 10.44 | 104,400 |
| 2007-06-13 | Levin Mark J (Director) | Sale | 10,000 | 10.33 | 103,260 |
| 2007-06-06 | Levin Mark J (Director) | Sale | 10,000 | 10.46 | 104,620 |
| 2007-05-30 | Levin Mark J (Director) | Sale | 10,000 | 10.75 | 107,500 |
| 2007-05-23 | Levin Mark J (Director) | Sale | 10,000 | 10.84 | 108,440 |
| 2007-05-16 | Levin Mark J (Director) | Sale | 10,000 | 10.93 | 109,300 |
| 2007-05-09 | Levin Mark J (Director) | Sale | 10,000 | 11.11 | 111,060 |
| 2007-05-02 | Levin Mark J (Director) | Sale | 10,000 | 11.15 | 111,530 |
| 2007-05-01 | Protopapas Anna (Senior Vice President) | Sale | 1,929 | 11.07 | 21,354 |
| 2007-04-18 | Levin Mark J (Director) | Sale | 10,000 | 12.00 | 119,990 |
| 2007-04-11 | Levin Mark J (Director) | Sale | 10,000 | 11.45 | 114,500 |
| 2007-04-09 | Protopapas Anna (Senior Vice President) | Sale | 4,250 | 11.56 | 49,130 |
| 2007-04-09 | Protopapas Anna (Senior Vice President) | Option Ex | 4,250 | 6.88 | 29,240 |
| 2007-04-04 | Levin Mark J (Director) | Sale | 10,000 | 11.42 | 114,190 |
| 2007-04-02 | Protopapas Anna (Senior Vice President) | Sale | 4,250 | 11.40 | 48,450 |
| 2007-04-02 | Protopapas Anna (Senior Vice President) | Option Ex | 4,250 | 6.88 | 29,240 |
| 2007-03-28 | Levin Mark J (Director) | Sale | 10,000 | 11.33 | 113,300 |
| 2007-03-26 | Protopapas Anna (Senior Vice President) | Sale | 8,500 | 11.38 | 96,730 |
| 2007-03-26 | Protopapas Anna (Senior Vice President) | Option Ex | 8,500 | 6.88 | 58,480 |
| 2007-03-21 | Levin Mark J (Director) | Sale | 10,000 | 10.92 | 109,170 |
| 2007-03-20 | Keating Laurie B. (SVP and General Counsel) | Sale | 12,400 | 11.00 | 136,400 |
| 2007-03-20 | Keating Laurie B. (SVP and General Counsel) | Option Ex | 12,400 | 8.41 | 104,284 |
| 2007-03-19 | Protopapas Anna (Senior Vice President) | Sale | 4,088 | 10.73 | 43,864 |
| 2007-03-19 | Protopapas Anna (Senior Vice President) | Option Ex | 4,088 | 7.99 | 32,663 |
| 2007-03-14 | Levin Mark J (Director) | Sale | 10,000 | 10.68 | 106,750 |
| 2007-03-13 | Keating Laurie B. (SVP and General Counsel) | Sale | 25,568 | 10.92 | 279,100 |
| 2007-03-13 | Keating Laurie B. (SVP and General Counsel) | Option Ex | 19,000 | 8.41 | 159,790 |
| 2007-03-12 | Protopapas Anna (Senior Vice President) | Sale | 1,970 | 10.64 | 20,960 |
| 2007-03-12 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 4,245 | 10.64 | 45,166 |
| 2007-03-09 | Protopapas Anna (Senior Vice President) | Sale | 3,833 | 10.59 | 40,572 |
| 2007-03-09 | Protopapas Anna (Senior Vice President) | Option Ex | 3,833 | 2.27 | 8,697 |
| 2007-03-08 | Dunsire Deborah (President and CEO) | Sale | 10,771 | 10.41 | 112,126 |
| 2007-03-08 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 6,173 | 10.41 | 64,260 |
| 2007-03-07 | Levin Mark J (Director) | Sale | 10,000 | 10.45 | 104,450 |
| 2007-02-21 | Levin Mark J (Director) | Sale | 10,000 | 11.14 | 111,359 |
| 2007-02-16 | Homcy Charles J (Director) | Sale | 27,774 | 11.24 | 312,179 |
| 2007-02-14 | Levin Mark J (Director) | Sale | 10,000 | 11.13 | 111,340 |
| 2007-02-12 | Keating Laurie B. (SVP and General Counsel) | Sale | 29,469 | 11.29 | 332,616 |
| 2007-02-12 | Keating Laurie B. (SVP and General Counsel) | Option Ex | 19,787 | 8.41 | 166,408 |
| 2007-02-12 | Tepper Robert I (President, R&D) | Sale | 22,500 | 11.36 | 255,600 |
| 2007-02-06 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 7,497 | 11.17 | 83,741 |
| 2007-02-02 | Bianchi Christophe (Executive Vice President) | Sale | 3,525 | 11.19 | 39,444 |
| 2007-01-24 | Homcy Charles J (Director) | Option Ex | 2,394 | 6.34 | 15,177 |
| 2007-01-23 | Homcy Charles J (Director) | Option Ex | 7,225 | 6.34 | 45,806 |
| 2007-01-04 | Protopapas Anna (Senior Vice President) | Sale | 4,524 | 11.02 | 49,854 |
| 2007-01-04 | Keating Laurie B. (SVP and General Counsel) | Sale | 5,318 | 11.02 | 58,604 |
| 2006-12-14 | Wild Anthony H (Director) | Option Ex | 8,948 | 9.67 | 86,554 |
| 2006-12-04 | Friel Robert F (Director) | Option Ex | 10,000 | 8.45 | 84,500 |
| 2006-11-21 | Homcy Charles J (Director) | Sale | 20,000 | 11.44 | 228,800 |
| 2006-11-21 | Homcy Charles J (Director) | Option Ex | 20,000 | 6.34 | 126,800 |
| 2006-11-20 | Tepper Robert I (President, R&D) | Sale | 15,000 | 11.49 | 172,425 |
| 2006-11-01 | Protopapas Anna (Senior Vice President) | Sale | 436 | 11.64 | 5,075 |
| 2006-10-30 | Tepper Robert I (President, R&D) | Sale | 60,000 | 11.88 | 712,680 |
| 2006-10-27 | Dunsire Deborah (President and CEO) | Sale | 112,500 | 11.52 | 1,295,437 |
| 2006-10-27 | Dunsire Deborah (President and CEO) | Option Ex | 112,500 | 9.77 | 1,099,462 |
| 2006-09-18 | Fanucci Marsha (SVP, Chief Financial Officer) | Sale | 10,003 | 10.95 | 109,532 |
| 2006-08-17 | Heidrich A Grant Iii (Director) | Sale | 95,980 | 10.42 | 1,000,015 |
| 2006-08-14 | Heidrich A Grant Iii (Director) | Sale | 71,300 | 9.87 | 703,731 |
| 2006-08-10 | Heidrich A Grant Iii (Director) | Sale | 7,000 | 9.87 | 69,090 |
| 2006-08-09 | Tepper Robert I (President, R&D) | Sale | 1,700 | 9.87 | 16,779 |
| 2006-08-09 | Heidrich A Grant Iii (Director) | Sale | 1,700 | 9.87 | 16,779 |
| 2006-07-31 | Tepper Robert I (President, R&D) | Option Ex | 75,000 | 3.94 | 295,275 |
| 2006-05-02 | Lander Eric S (Director) | Option Ex | 80,000 | 4.81 | 384,960 |
| 2006-04-24 | Heidrich A Grant Iii (Director) | Option Ex | 80,000 | 4.81 | 384,960 |
| 2006-03-20 | Kucherlapati Raju S (Director) | Option Ex | 80,000 | 4.81 | 384,960 |
Insider trading activities including stock purchases, stock sales, and option exercises of MLNM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Millennium Pharmaceuticals Inc (symbol MLNM, CIK number 1002637) see the Securities and Exchange Commission (SEC) website.